Influence of Ranibizumab versus laser photocoagulation on radiation retinopathy (RadiRet) - a prospective randomized controlled trial

PURPOSE: To demonstrate superiority of intravitreal ranibizumab 0.5 mg compared to focal and peripheral laser treatment in patients with radiation retinopathy for choroidal melanoma. METHODS: Inclusion criteria were as follows: patients with radiation retinopathy and visual acuity impairment due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Seibel, Ira, Vollhardt, Daniela, Riechardt, Aline I., Rehak, Matus, Schmied, Sabine, Schiller, Petra, Zeitz, Oliver, Hellmich, Martin, Joussen, Antonia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575494/
https://www.ncbi.nlm.nih.gov/pubmed/32112140
http://dx.doi.org/10.1007/s00417-020-04618-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575494/
https://www.ncbi.nlm.nih.gov/pubmed/32112140
http://dx.doi.org/10.1007/s00417-020-04618-7

Ejemplares similares